tiprankstipranks
Advertisement
Advertisement

NVS Stock Latest News

Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
The FlyMidday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
2d ago
U
CG
Novartis: Excellergy Deal Adds Long‑Dated Pipeline Risk Amid LOE Headwinds, Supporting Sell Rating
PremiumRatings
Novartis: Excellergy Deal Adds Long‑Dated Pipeline Risk Amid LOE Headwinds, Supporting Sell Rating
2d ago
NVS
Novartis to buy biotech company Excellergy for up to $2B
PremiumThe Fly
Novartis to buy biotech company Excellergy for up to $2B
2d ago
NVS
Novartis (NVS) Stock Falls on $2B Excellergy Acquisition to Expand Allergy Portfolio
PremiumMarket News
Novartis (NVS) Stock Falls on $2B Excellergy Acquisition to Expand Allergy Portfolio
2d ago
NVS
Novartis price target raised to $170 from $143 at Morgan Stanley
PremiumThe Fly
Novartis price target raised to $170 from $143 at Morgan Stanley
3d ago
NVS
Novartis: Late-Stage Pipeline and Pelacarsen Upside Support Buy Rating Despite Patent Headwinds
PremiumRatingsNovartis: Late-Stage Pipeline and Pelacarsen Upside Support Buy Rating Despite Patent Headwinds
3d ago
NVS
Novartis: Strengthened Growth Outlook and Undervalued Late‑Stage Pipeline Support Buy Rating and Higher Target Price
Premium
Ratings
Novartis: Strengthened Growth Outlook and Undervalued Late‑Stage Pipeline Support Buy Rating and Higher Target Price
3d ago
NVS
Merck’s offer for Terns leaves room for another bidder, says William Blair
Premium
The Fly
Merck’s offer for Terns leaves room for another bidder, says William Blair
4d ago
MRK
NVS
Merck’s offer for Terns leaves room for another bidder, says William Blair
PremiumThe Fly
Merck’s offer for Terns leaves room for another bidder, says William Blair
4d ago
MRK
NVS
Clear Street says Merck’s bet on TERN-701 sharpens investment case for ELVN-001
PremiumThe Fly
Clear Street says Merck’s bet on TERN-701 sharpens investment case for ELVN-001
4d ago
MRK
NVS
Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims
PremiumMarket News
Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims
5d ago
NVS
MREO
Novartis price target raised to $178 from $163 at BofA
PremiumThe Fly
Novartis price target raised to $178 from $163 at BofA
6d ago
NVS
Novartis: Strengthened Late-Stage Pipeline Underpins Upgraded CHF140 Target and Buy Rating
PremiumRatingsNovartis: Strengthened Late-Stage Pipeline Underpins Upgraded CHF140 Target and Buy Rating
6d ago
NVS
Novartis Stock (NVS) Climbs after Paying $3B for “Mutant”- Fighting Breast Cancer Drug
Premium
Market News
Novartis Stock (NVS) Climbs after Paying $3B for “Mutant”- Fighting Breast Cancer Drug
9d ago
NVS
Novartis to acquire Pikavation Therapeutics from Synnovation Therapeutics
Premium
The Fly
Novartis to acquire Pikavation Therapeutics from Synnovation Therapeutics
9d ago
NVS
Novartis initiated with a Market Perform at Bernstein
PremiumThe Fly
Novartis initiated with a Market Perform at Bernstein
10d ago
NVS
Novartis Raises $11 Billion in Multi-Tranche U.S. Bond Offering
PremiumCompany Announcements
Novartis Raises $11 Billion in Multi-Tranche U.S. Bond Offering
10d ago
6K
NVS
Trump Trade: President issues short-term waiver of Jones Act
PremiumThe Fly
Trump Trade: President issues short-term waiver of Jones Act
11d ago
AZN
BMY
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
PremiumThe Fly
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
11d ago
AZN
BMY
Novartis price target raised to CHF 95 from CHF 89 at HSBC
PremiumThe FlyNovartis price target raised to CHF 95 from CHF 89 at HSBC
12d ago
NVS
District court rules federal limits to vaccines not based on science, NYT says
Premium
The Fly
District court rules federal limits to vaccines not based on science, NYT says
12d ago
AZN
BMY
Novartis receives FDA approval for Cosentyx for patients aged 12 and older
Premium
The Fly
Novartis receives FDA approval for Cosentyx for patients aged 12 and older
16d ago
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >